IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 35 filers reported holding IKENA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,986 | -34.0% | 2,999 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $19,673 | +90.1% | 2,999 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $10,347 | +129237.5% | 2,999 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $8 | -99.9% | 2,999 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $11,000 | -15.4% | 2,999 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $13,000 | -27.8% | 2,999 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $18,000 | -52.6% | 2,999 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $38,000 | – | 2,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |